Mineralys Therapeutics, Inc. (MLYS)

$23.97 +0.8%

EARNINGS ANALYTICS

event_upcoming Next Earnings: 2026-08-12 HIGH CONFIDENCE

Across 14 earnings reports since Mar 15, 2023, Mineralys Therapeutics, Inc. (MLYS) has a clear post-earnings pattern. It moves ±6.09% on average after reporting and finishes higher 35.7% of the time. Its largest post-earnings gain was +10.04% (Feb 12, 2025) and its largest decline was -22.82% (Aug 13, 2024). The next earnings report is predicted for 2026-08-12 (high confidence).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.09%

Positive %

35.7%

Negative %

64.3%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 06, 2026	☽ POST	$29.61	$30.68	$30.16	56,093	-2.62%	open_in_new
Mar 12, 2026	☽ POST	$27.92	$27.92	$26.99	1,168,500	-2.96%	open_in_new
Nov 10, 2025	☽ POST	$38.01	$44.89	$44.50	2,837,200	+5.87%	open_in_new
Aug 12, 2025	☽ POST	$13.21	$13.61	$13.51	889,700	+0.37%	open_in_new
May 12, 2025	☽ POST	$14.20	$15.47	$15.01	876,100	+1.2%	open_in_new
Feb 12, 2025	☀ PRE	$10.61	$11.09	$10.63	395,600	+10.04%	open_in_new
Nov 12, 2024	☀ PRE	$13.51	$14.73	$13.38	397,600	-10.32%	open_in_new
Aug 13, 2024	☽ POST	$11.50	$11.88	$11.83	117,700	-22.82%	open_in_new
May 09, 2024	☀ PRE	$14.68	$15.00	$14.27	189,600	-2.59%	open_in_new
Mar 21, 2024	☀ PRE	$13.35	$13.73	$13.09	422,300	-2.24%	open_in_new
Nov 07, 2023	☽ POST	$8.16	$9.03	$8.75	382,100	-6.74%	open_in_new
Aug 07, 2023	☽ POST	$13.03	$13.11	$12.50	189,700	+6.96%	open_in_new
May 15, 2023	☽ POST	$16.48	$16.56	$16.19	87,400	-4.57%	open_in_new
Mar 15, 2023	☽ POST	$16.53	$16.88	$16.35	222,100	-5.93%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.09%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description SCHEDULE 13D/A

4 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
144	20260610	open_in_new SEC.gov
424B5	20260603	open_in_new SEC.gov
8-K	20260603	open_in_new SEC.gov
8-K	20260603	open_in_new SEC.gov
8-K	20260522	open_in_new SEC.gov
4	20260519	open_in_new SEC.gov
144	20260518	open_in_new SEC.gov
144	20260513	open_in_new SEC.gov
4	20260513	open_in_new SEC.gov
10-Q	20260506	open_in_new SEC.gov

Frequently asked about MLYS earnings

When does Mineralys Therapeutics, Inc. report earnings next? expand_more

Mineralys Therapeutics, Inc. (MLYS)'s next earnings date is predicted (high confidence) for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does MLYS stock move after earnings? expand_more

Over 14 reports, MLYS has moved an average of ±6.09% the session after earnings, closing higher 35.7% of the time.

What was MLYS's biggest post-earnings move? expand_more

MLYS's largest post-earnings gain on record was +10.04% on Feb 12, 2025, and its largest decline was -22.82% on Aug 13, 2024.

Where can I find Mineralys Therapeutics, Inc.'s SEC filings? expand_more

All of Mineralys Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.